Advanced Therapy Incubator and Accelerator Programs

Jumpstarting promising ideas and enhancing access for early-stage cell and gene therapy developers

abstract image of colored light representing Charles River’s Cell and Gene Therapy Accelerator Program

  • Incubator Program (CIP): Incubates biotechnology developers in the discovery phase, 24+ months from Investigational New Drug (IND) or Clinical Trial Application (CTA) submission.
  • Accelerator Program (CAP): Accelerates advanced therapy developers 18-24 months from IND or CTA submission.

Advanced therapy developers who align with Charles River's strategic areas of interest and meet the following selection criteria are invited to apply to be part of the next cohort:

  • Targeting a significant, unmet medical or market need
  • Conducting transformational scientific and/or technological approach
  • Demonstrating a strong team and financial solvency

Complete the form to take the first step, and a member of our team will be in touch to discuss additional information required to support your application.